LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(Q2)Dec 28, 2024 | (Q1)Sep 28, 2024 | (FY)Jun 29, 2024 | (Q4)Jun 29, 2024 | (Q3)Mar 30, 2024 | (Q2)Dec 30, 2023 | (Q1)Sep 30, 2023 | (FY)Jul 1, 2023 | (Q4)Jul 1, 2023 | (Q3)Apr 1, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -38.78%506M | 58.70%119.5M | 28.75%1.26B | -36.06%256M | -12.99%97.8M | 30.61%826.5M | 144.19%75.3M | 14.30%975.2M | 69.09%400.4M | 112.4M |
Net income from continuing operations | -3.69%310.4M | -4.31%186.6M | -12.82%816M | -28.92%159.3M | -25.33%139.4M | -2.30%322.3M | -0.15%195M | 9.31%936M | 18.70%224.1M | --186.7M |
Depreciation and amortization | 1.09%55.5M | -4.85%54.9M | 2.14%229M | 10.14%103.2M | -68.50%13.2M | 22.54%54.9M | 31.74%57.7M | 8.83%224.2M | 61.83%93.7M | --41.9M |
Deferred tax | -75.76%10.4M | -66.67%12.2M | -93.93%2.5M | -627.08%-50.6M | -5,180.00%-26.4M | 21.53%42.9M | 1,243.75%36.6M | 37.79%41.2M | -61.13%9.6M | ---500K |
Other non cash items | -765.85%-27.3M | -344.29%-31.1M | 3.47%-50M | -561.36%-29.1M | -130.77%-18M | 123.70%4.1M | 68.61%-7M | -609.59%-51.8M | -131.58%-4.4M | ---7.8M |
Change In working capital | -96.27%14.1M | 46.06%-122.5M | 164.85%167.9M | -5.33%51.5M | 73.82%-34.5M | 73.39%378M | 43.15%-227.1M | 31.42%-258.9M | 202.45%54.4M | ---131.8M |
-Change in receivables | -290.79%-14.5M | 3.42%-53.7M | -184.58%-37.3M | -50.87%25.4M | -223.53%-14.7M | 305.41%7.6M | -251.90%-55.6M | 145.94%44.1M | 241.64%51.7M | --11.9M |
-Change in inventory | -51.57%64.7M | -508.72%-181.4M | 71.94%85.8M | -48.72%-5.8M | -128.84%-12.2M | -30.92%133.6M | 83.62%-29.8M | 116.01%49.9M | 96.74%-3.9M | --42.3M |
-Change in payables and accrued expense | -132.18%-75.2M | 238.16%124.9M | 173.63%140.7M | -29.24%96.8M | 52.00%-99.4M | 1,800.00%233.7M | 32.08%-90.4M | -371.83%-191.1M | -13.31%136.8M | ---207.1M |
-Change in other current assets | 19.43%29.5M | 73.32%-11.5M | 99.90%-100K | 35.41%-73.7M | 57.26%92M | -62.86%24.7M | 61.38%-43.1M | -225.89%-100.7M | -22.42%-114.1M | --58.5M |
-Change in other current liabilities | 144.44%9.6M | 90.24%-800K | 65.30%-21.2M | 154.66%8.8M | 99.47%-200K | 57.23%-21.6M | -119.11%-8.2M | -564.13%-61.1M | -142.04%-16.1M | ---37.4M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -38.78%506M | 58.70%119.5M | 28.75%1.26B | -36.06%256M | -12.99%97.8M | 30.61%826.5M | 144.19%75.3M | 14.30%975.2M | 69.09%400.4M | --112.4M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 224.85%789.3M | 933.77%190.1M | -18,378.95%-1.04B | -1,492.55%-555.8M | 522.25%168.9M | -854.98%-632.2M | -115.53%-22.8M | 102.25%5.7M | -141.60%-34.9M | -40M |
Net PPE purchase and sale | -35.53%-30.9M | -22.49%-25.6M | 40.88%-108.9M | -33.53%-46.2M | 53.43%-19M | 72.02%-22.8M | 23.44%-20.9M | -96.17%-184.2M | -84.04%-34.6M | ---40.8M |
Net investment purchase and sale | 234.59%820.2M | 11,452.63%215.7M | -591.31%-933M | -169,766.67%-509.6M | 23,387.50%187.9M | -4,083.01%-609.4M | -101.09%-1.9M | 218.91%189.9M | -100.29%-300K | --800K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 224.85%789.3M | 933.77%190.1M | -18,378.95%-1.04B | -1,492.55%-555.8M | 522.25%168.9M | -854.98%-632.2M | -115.53%-22.8M | 102.25%5.7M | -141.60%-34.9M | ---40M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -212.46%-6.7B | 50.13%-74.5M | 603.37%5.21B | -94.31%-519.2M | 71.36%-75.6M | 2,239.53%5.96B | 33.95%-149.4M | 41.74%-1.04B | 13.75%-267.2M | -264M |
Net issuance payments of debt | -175.82%-4.61B | 95.45%-300K | 18,115.06%5.62B | -8,216.67%-449.1M | -1.54%-6.6M | 93,684.62%6.08B | 48.44%-6.6M | -131.68%-31.2M | -105.36%-5.4M | ---6.5M |
Net common stock issuance | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 56.03%-703.5M | 42.46%-201.5M | ---202M |
Cash dividends paid | 9.73%-72.4M | -1.50%-81.4M | -13.45%-321.4M | -16.50%-80.5M | -15.00%-80.5M | -12.17%-80.2M | -10.32%-80.2M | -7.15%-283.3M | -12.18%-69.1M | ---70M |
Proceeds from stock option exercised by employees | 2,400.00%72.5M | 10,325.00%41.7M | -29.64%27.3M | 20.59%12.3M | -20.95%11.7M | -62.34%2.9M | -93.44%400K | -48.06%38.8M | 308.00%10.2M | --14.8M |
Net other financing activities | -62.00%-76.3M | 45.24%-34.5M | -97.88%-112.2M | -35.71%-1.9M | 33.33%-200K | -1,419.35%-47.1M | -21.39%-63M | 34.75%-56.7M | -16.67%-1.4M | ---300K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -212.46%-6.7B | 50.13%-74.5M | 603.37%5.21B | -94.31%-519.2M | 71.36%-75.6M | 2,239.53%5.96B | 33.95%-149.4M | 41.74%-1.04B | 13.75%-267.2M | ---264M |
Net cash flow | ||||||||||
Beginning cash position | 938.88%6.46B | 745.89%6.14B | -8.07%726.1M | 994.65%6.98B | 723.07%6.83B | 18.16%622.1M | -8.07%726.1M | -60.66%789.8M | -20.94%637.2M | --830.2M |
Current changes in cash | -187.86%-5.41B | 342.62%235.1M | 9,969.27%5.43B | -933.16%-819M | 199.74%191.1M | 2,035.68%6.15B | 61.21%-96.9M | 95.33%-55M | 801.83%98.3M | ---191.6M |
Effect of exchange rate changes | -226.51%-73.5M | 1,308.45%85.8M | -40.23%-12.2M | -50.00%-14.1M | -3,407.14%-49.1M | 272.44%58.1M | 47.41%-7.1M | 77.92%-8.7M | 65.31%-9.4M | ---1.4M |
End cash Position | -85.61%983.4M | 938.88%6.46B | 745.89%6.14B | 745.89%6.14B | 994.65%6.98B | 723.07%6.83B | 18.16%622.1M | -8.07%726.1M | -8.07%726.1M | --637.2M |
Free cash flow | -40.89%475.1M | 72.61%93.9M | 44.97%1.15B | -42.65%209.8M | 10.06%78.8M | 45.78%803.7M | 127.52%54.4M | 4.17%791M | 67.80%365.8M | --71.6M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |